Active: new deal Jan 2026 Verified 5 Nov 2026
Dynamk Life Sciences
Life science investor focused on therapeutic enabling technologies such as biomanufacturing, tools and automation, AI applications and contract services. Based in New York, NY.
- Type
- VC firm
- Location
- New York, New York, United States
- Stages
- Series A, Series B
- Sectors
- Biotech, Healthtech and life sciences, AI
- Fund size / AUM
- $57.4M Dynamk Life Sciences Fund (Form D offering, 2021); $56.3M gross private fund assets (Form ADV; private funds: 1, of which venture capital: 1)
- Latest fund or filing
- 23 Dec 2024
- Website
- www.avant.bio
Contacts on file
For Dynamk Life Sciences, the paid file holds: 8 named decision-makers with roles; how to pitch (the route the firm publishes); LinkedIn page.
Get US Complete, $197 Free sample
One-time payment. No subscription. No account.
Sources
- www.sec.gov/Archives/edgar/data/1972528/000197252824000002/
- adviserinfo.sec.gov/firm/summary/327673
- avant.bio/
- avant.bio/contact/
- www.sec.gov/Archives/edgar/data/1718277/000171827721000001/
- avant.bio/our-team/
Last checked 5 Nov 2026. Is something wrong? Tell us.
Appears in 30 lists
Series B investors in New York (29)Biotech investors in New York (29)Series B biotech investors in the US (34)Series A investors in New York (49)Series A biotech investors in the US (59)Series B healthtech investors in the US (69)Series B biotech investors (73)Healthtech investors in New York (100)Series B AI investors in the US (126)Series A biotech investors (153)AI investors in New York (159)Series B healthtech investors (160)Series A healthtech investors in the US (164)Series B investors in the US (165)Series B AI investors (204)Series A AI investors in the US (280)Biotech venture capital firms in the US (297)Series B investors (339)Series A investors in the US (372)Series A healthtech investors (401)Venture capital firms in New York (440)Biotech investors (484)Series A AI investors (500)Healthtech venture capital firms in the US (709)Series A investors (864)AI venture capital firms in the US (1,112)Healthtech investors (1,207)Active venture capital firms in the US (1,574)AI investors (1,576)Venture capital firms in the US (2,975)